Search results

Congress marks watershed moment for nuclear medicine and ANSTO

Consortium will map the 86 billion nerve cells, 100 trillion connections and neurotransmitters in the human brain.

Low-cost X-ray detectors featuring high sensitivity, durability and physical flexibility are required in fields ranging from medical imaging to defence. In this study, a new material for X-ray detection was coupled with inkjet printing to produce a series of prototype X-ray detectors.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.  

Designed for Radiation Safety Officers working in industrial settings responsible for radioactive substances and/or radiation apparatus. ANSTO is a recognised leader in radiation safety training, delivering industry and regulator-approved courses for licences including IA7, IA8, IA10, IA12, IA19 & IA41.

A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.

Biochemical and structural studies to elucidate protein interactions of the new compounds and target molecules included X-ray diffraction at the Australian Synchrotron.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

Research on lunar meteorite and moon crater analogues coincides with Science Week.